Literature DB >> 11736697

Contrast-enhanced MR imaging in the diagnosis and preservation of cardiac viability.

H J Smith.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11736697     DOI： 10.1080/028418501127347232

Source DB:  PubMed          Journal:  Acta Radiol        ISSN： 0284-1851            Impact factor:   1.990


× No keyword cloud information.
  2 in total

1.  First clinical experience with the magnetic resonance imaging contrast agent and superoxide dismutase mimetic mangafodipir as an adjunct in cancer chemotherapy-a translational study.

Authors:  Jan Olof G Karlsson; Karin Adolfsson; Bo Thelin; Per Jynge; Rolf Gg Andersson; Ursula G Falkmer
Journal:  Transl Oncol       Date:  2012-02-01       Impact factor: 4.243

2.  Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity.

Authors:  Tino Kurz; Derek Grant; Rolf Gg Andersson; Robertson Towart; Michelandrea De Cesare; Jan Olof G Karlsson
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.